Human papillomavirus vaccines: Why the time is right to implement immunization and surveillance programs in Canada. - Wikidata - wikimedia - TriplyDB

Human papillomavirus vaccines: Why the time is right to implement immunization and surveillance programs in Canada.

Human papillomavirus vaccines: Why the time is right to implement immunization and surveillance programs in Canada.

http://www.wikidata.org/entity/Q37018243

about

When do sexual partnerships need to be accounted for in transmission models of human papillomavirus?Epidemiological impact of a genital herpes type 2 vaccine for young females.HPV Vaccine Uptake Among Canadian Youth and The Role of the Nurse Practitioner.Ethnic Variations in Perception of Human Papillomavirus and its Vaccination among Young Women in Nepal .

P2860

Q33858647-14220E6A-30A8-4C04-B26F-CDF4566DDE46 Q34446935-9C59A000-90CE-4A97-B161-6D57720BBBAC Q38561384-8E3DF26E-9E7F-4DBB-A639-CE1BFEE9805F Q42013807-F22FA1AD-38E6-4AAD-817E-11B313B3893B

P2860

Human papillomavirus vaccines: Why the time is right to implement immunization and surveillance programs in Canada.

http://www.wikidata.org/entity/Q37018243

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Human papillomavirus vaccines: ...... rveillance programs in Canada.

@en

Human papillomavirus vaccines: ...... rveillance programs in Canada.

@nl

type

label

Human papillomavirus vaccines: ...... rveillance programs in Canada.

@en

Human papillomavirus vaccines: ...... rveillance programs in Canada.

@nl

prefLabel

Human papillomavirus vaccines: ...... rveillance programs in Canada.

@en

Human papillomavirus vaccines: ...... rveillance programs in Canada.

@nl

P1433

Q37018243-C6767B7B-2159-44AB-B7C8-EDCD502F649D

P1476

Q37018243-383433F7-EE00-4908-90B5-4B8869DC71C9

P2093

Q37018243-3D21ABC3-1C69-4F3E-8EEF-F9F8027DFD3E

Q37018243-85AA3864-51BE-43BB-B7E8-8F15A1E43141

Q37018243-F754CCDD-DFDD-4E5F-A89D-9B07CCD8A08E

P2860

Q37018243-139890F6-5E3D-4176-8EE9-4C80D5E3C88C

Q37018243-161DDBF2-64CD-4062-BF75-E1AA3CEC9D90

Q37018243-24B8D25B-A9F6-462D-A929-B21CB6BFC72A

Q37018243-5021D4B4-A8D7-4FF4-9C65-FC57FE0450E1

Q37018243-502A9F4D-2836-409F-8891-DD60F3F6061A

Q37018243-5582D754-A565-447C-8977-8357ED0A7F33

Q37018243-559621B8-8C08-4EF9-A752-717B29B18F19

Q37018243-59A074B9-7F4B-4F71-A52E-8941CEDFCC09

Q37018243-61F72588-08A5-4FE9-A20F-09506903742E

Q37018243-6B9C1EE8-0E7B-40FF-A9C8-9505930CB361

P304

Q37018243-785CD575-83DC-43BD-BE59-BBD8EAB0715A

P31

Q37018243-939D7AF0-C251-4D3D-9B3D-19A15D26D23D

P356

Q37018243-DE1F0AB5-155B-4DDA-BB8A-32426D6BB3AC

P407

Q37018243-A0326B2C-681A-479D-B251-E58656006F3B

P433

Q37018243-7441C1D1-9B6A-4CA0-8D4F-E5CEBD45288E

P478

Q37018243-BE7DE1B3-A2A7-4E3D-B819-8618CBA5DB32

P577

Q37018243-1772D627-B781-47AE-A414-205C82CF0B66

P698

Q37018243-A5D5E830-3BC2-412E-9D62-ECC381ED3E78

P921

Q37018243-9DE15554-B68E-4442-BCA5-9B7AC1AE5014

Q37018243-F9F11B30-EC88-4F87-8CD3-0F12AD4C76EB

P932

Q37018243-F5B6ABCF-F0AB-41CB-B0D4-798F4CE7A2C5

P356

P1433

Canadian Journal of Infectious Diseases & Medical Microbiology

P1476

Human papillomavirus vaccines: ...... rveillance programs in Canada.

@en

P2093

Ameeta Singh

http://www.w3.org/2001/XMLSchema#string

Roberta I Howlett

http://www.w3.org/2001/XMLSchema#string

Tom Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Sex and HIV Education Programs: Their Impact on Sexual Behaviors of Young People Throughout the World

The environment and disease: association or causation? 1965.

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Risk of female human papillomavirus acquisition associated with first male sex partner.

Human papillomavirus, vaccines and women's health: questions and cautions.

Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.

Appropriate use of cervical cancer vaccine.

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

P304

294-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2008/813065

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19436510

http://www.w3.org/2001/XMLSchema#string

P921

P932

2604776

http://www.w3.org/2001/XMLSchema#string